Advertisement
YOU ARE HERE: LAT HomeCollectionsCell Transplants
IN THE NEWS

Cell Transplants

HEALTH
March 14, 2005 | Linda Marsa, Special to The Times
Hundreds of diabetics can now live without daily injections after receiving transplants of insulin-producing cells. These cells, taken from the pancreases of several cadavers, quickly set to work inside their new hosts to produce the glucose-regulating hormone. But most diabetics aren't candidates for the transplants. There simply aren't enough organs available to provide the cells.
Advertisement
NEWS
September 17, 1992 | THOMAS H. MAUGH II, TIMES SCIENCE WRITER
Major advances in healing damaged spines, the most important cause of paralysis, were reported Wednesday by two independent research groups. One group used fetal cell transplants to restore near-normal function in the rear legs of cats that had suffered paralyzing spinal damage, apparently the first report of such success in any mammal.
CALIFORNIA | LOCAL
May 7, 1992 | THOMAS H. MAUGH II, TIMES SCIENCE WRITER
Two types of experimental surgical procedures have significantly improved the conditions of patients with Parkinson's disease, surgeons said here Wednesday. Two teams of researchers independently reported that in a total of 11 patients, grafts of fetal tissue obtained during abortions sharply reduced tremors and rigidity and increased control of limb functions.
NEWS
April 16, 1988 | THOMAS H. MAUGH II, Times Science Writer
When diabetic Rich Shultz received a transplant of pancreatic cells taken from an aborted human fetus two years ago, the Santa Barbara man became a participant in a fast-growing but controversial field of experimental therapy. Many biomedical researchers believe that fetal tissues and cells have enormous potential for helping hundreds of thousands of people with hormone-deficiency disorders such as Parkinson's, Huntington's and Alzheimer's diseases, as well as diabetes.
NEWS
September 9, 1989 | THOMAS H. MAUGH II, Times Science Writer
Researchers are developing a bold and unusual new type of transplant operation that they think may eventually be able to restore vision in individuals blinded by the loss of photoreceptor cells--the cells in the eye that convert light into an electrical signal transmitted to the brain.
CALIFORNIA | LOCAL
November 19, 1990 | From Times staff and wire reports
The first cancer therapy using genetically altered living cells was approved last week, and doctors at the National Institutes of Health said the first patient should start treatment within a few weeks. Steven A. Rosenberg said his team has been poised to start the revolutionary gene therapy in patients critically ill with advanced melanoma, a deadly skin cancer, and was only awaiting the final approval from the Food and Drug Administration.
NEWS
July 2, 1998 | From The Washington Post
Doctors at the University of Pittsburgh Medical Center have implanted laboratory-grown human nerve cells, originally obtained from a young man's cancer, into the brain of a 62-year-old stroke victim in an effort to reverse the woman's brain damage.
NEWS
July 21, 2001 | AARON ZITNER, TIMES STAFF WRITER
More than 50 ethics scholars have signed a letter asking President Bush to support medical research using cells from human embryos, and 61 U.S. senators went on record Friday as supporting the research. "We urge you not to close this door on what might be a critical path to the human future," said the ethicists' letter, which was signed by scholars of Lutheran, Baptist, Jewish, Catholic and other faiths.
NEWS
October 24, 2000 | From Associated Press
Congress will wait until next year before deciding whether to remove key restrictions on federal funding for embryonic stem-cell research that advocates say could lead to cures for Parkinson's, Alzheimer's and other diseases. A final attempt to get a bill through the Senate late last month was blocked by Sen. Sam Brownback (R-Kan.), a leading abortion opponent. He said embryonic cell research is "illegal, is immoral and it's unnecessary." Supporters of the research, including Sen.
Los Angeles Times Articles
|